Despite becoming produced for under $five per month, copyright carries a retail selling price that is difficult to justify. The significant hole concerning manufacturing charges and pricing raises crucial questions on the pharmaceutical industry's pricing tactics.In October 2024, Novo Nordisk released a review on scientific journal Nature a couple